We’re already well into the year, and I think it’s the right moment to pause and take stock of the AI tools that have stood ...

Incyte today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from ...

Intensity Therapeutics, Inc. , ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral ...